SHL Telemedicine Executive and Leadership Team

David Arnon, the Chief Executive Officer at SHL Telemedicine, directs the overarching corporate strategy for personal telemedicine systems. Arnon oversees the integration of telephonic and Internet communication technology to enhance cardiovascular patient outcomes. By managing the expansion of medical call center services, the Chief Executive Officer ensures that the organization maintains a competitive edge within the healthcare community. This leadership role involves constant collaboration with the board to refine the long-term vision for remote diagnostic tools. David Arnon drives operational excellence across all departments, ensuring that the company meets the rigorous demands of the international healthcare market. Through the implementation of scalable digital health solutions, the Chief Executive Officer secures the company's position as a leader in cardiovascular monitoring. Arnon prioritizes the development of user-centric devices that simplify the patient experience while maintaining high clinical standards for all subscribers.

Lior Haalman, the Chief Financial Officer at SHL Telemedicine, manages the fiscal health and capital allocation strategies for the organization. Haalman oversees financial reporting, budgeting, and investment planning to support the development of advanced telemedicine devices. By analyzing market trends in the health software sector, the Chief Financial Officer ensures that the company maintains the necessary liquidity to fund research and development initiatives. This role requires close coordination with the executive team to align financial goals with the broader mission of providing cardiovascular care. Lior Haalman drives cost-efficiency across all operational units, optimizing the resource distribution required for global service delivery. Through rigorous financial oversight, the Chief Financial Officer mitigates fiscal risks while identifying new growth opportunities in the telemedicine market. Haalman maintains transparency with stakeholders, ensuring that the financial trajectory supports the long-term sustainability of the company's medical call center services.

Yoram Alroy, the President & Chairman at SHL Telemedicine, leads the board of directors and shapes the high-level governance of the company. Alroy oversees the strategic direction of the organization, focusing on the long-term impact of telemedicine systems on cardiovascular health. By fostering relationships with key industry partners and the healthcare community, the President & Chairman ensures that the company remains at the forefront of medical innovation. This leadership role involves setting the agenda for board meetings and guiding the executive team toward achieving core business objectives. Yoram Alroy drives the vision for international market penetration, leveraging deep industry expertise to navigate the evolving landscape of digital health. Through the oversight of corporate governance, the President & Chairman maintains the highest standards of accountability and performance. Alroy ensures that the company's mission to provide accessible, high-quality medical monitoring remains the primary focus of all strategic initiatives.

Irit Philip, the Chief Legal Officer at SHL Telemedicine, directs all regulatory compliance and legal affairs for the organization. Philip oversees the complex legal frameworks governing medical device marketing and the provision of remote healthcare services. By managing intellectual property portfolios and contractual obligations, the Chief Legal Officer ensures that the company operates within the strict guidelines of international health regulations. This leadership role involves advising the board on governance matters and mitigating potential liabilities associated with telemedicine technology. Irit Philip drives the development of internal policies that protect the integrity of patient data and the security of communication systems. Through proactive legal strategy, the Chief Legal Officer supports the company's expansion into new markets while maintaining adherence to regional healthcare standards. Philip ensures that all corporate activities align with the ethical requirements of the medical community, safeguarding the reputation of the organization.